☆ 4.5 Letter

Letter to editor regarding effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Get Full Text
Add to Collection

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 191, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2022.110017

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.